Application of Neostigmine Intramuscular Injection Combined with Electroacupuncture and Ultrashort Wave Therapy in Patients with Postpartum Urinary Retention
Objective:To explore the application effect of Neostigmine intramuscular injection combined with electroacupuncture and ultrashort wave therapy in patients with postpartum urinary retention(PUR).Method:A total of 84 PUR patients admitted to Ganzhou Women and Children's Health Care Hospital from March 2022 to October 2023 were selected,and they were divided into a control group(42 cases)and an observation group(42 cases)by drawing lots.The control group was treated with intramuscular injection of Neostigmine,while the observation group was treated with intramuscular injection of Neostigmine combined with electroacupuncture and ultrashort wave therapy.The treatment effects,first urination time and urine volume,residual urine volume in the bladder,urinary pain and difficulty in urination,and the incidence of indwelling catheters between two groups were compared.Result:The total effective rate of treatment in the observation group was higher than that in the control group,first urination time was earlier compared to the control group and urine output was more,the differences were statistically significant(P<0.05).2 hours after treatment,the residual urine volume in the bladder of the observation group was lower than that of the control group(P<0.05);at 2 hours and 1 day after treatment,the scores of urinary pain and difficulty in urination were lower than those of the control group,the differences were statistically significant(P<0.05).The incidence of indwelling catheters in the observation group was lower than that in the control group,the difference was statistically significant(P<0.05).Conclusion:The combination of Neostigmine intramuscular injection and electroacupuncture with ultrashort wave therapy is effective for PUR patients,which can shorten urination time,reduce residual urine volume in the bladder,alleviate urinary pain and difficulty,and reduce the risk of indwelling catheters.
万方数据
维普
